Home›News Center›SGS Continues to Invest in Bioanalytical Testing to Increase Efficiency and Regulatory Compliance at Its Poitiers, France, Laboratory

March 8, 2016

SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, has announced that it has fully installed and validated an immune response module (IRM) as part of its Watson laboratory information management system (LIMS) at its facility in Poitiers, France. This new module will enable higher throughput of samples, and electronic data capture to ensure integrity of information in regulatory submission and acceptances.

The investment in the IRM is the latest strategic step for the company in its key business area of large molecule bioanalysis. The module allows for faster immunogenicity data processing and easier consolidation of sample data, reducing time and cost for clients. The integration of the module into the existing LIMS infrastructure means bioanalytical studies can be managed by one single tool, and clients' immunogenicity data can be stored and processed within a secure environment.

The new module has been fully validated by SGS and can be used for GCP and GLP compliant studies.

'For our clients, this investment will reduce the time spent processing complex bioanalytical data and also ensure that any regulatory submission based upon results and data generated by SGS will stand up to scrutiny,' commented Alain Renoux, Laboratory Director of SGS Life Sciences Poitiers. 'As a company, we are seeing much greater demand for bioanalytical testing as this field of research widens, and SGS continues to invest in areas that benefit our clients' long term goals.'

With 20 laboratories offering contract analytical and bioanalytical services, SGS leverages its wholly-owned global network, present in North America, Europe, and Asia, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the bio/pharmaceutical market, SGS also provides Phase I-IV clinical trial management, and services encompassing data management and statistics, PK/PD modeling and simulation, pharmacovigilance and regulatory consultancy.

For further information, please contact:

Ferdinand Dabu
Life Sciences - Global Marketing Director
Agriculture, Food and Life
SGS, 75 Passaic Avenue, Fairfield, NJ 07004, USA
t: +1-973-287-1219
www.sgs.com/lifescience

Richard Kerns
President
NEPR
t: +44 (0)161 728 5880

About SGS

SGS is the world's leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 85,000 employees, SGS operates a network of over 1,800 offices and laboratories around the world.

SGS SA issued this content on 08 March 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 08 March 2016 13:05:22 UTC

Original Document: http://www.sgs.com/en/news/2016/03/sgs-announces-installation-of-new-immune-response-model-at-poitiers-france-facility